Blog

The Woodruff Lab contributes to the Women’s Health Research Institute and Oncofertility Consortium blogs. Read the latest information disseminated from these blogs below:  

Presentations from the 2015 Conference- Advances in Vitrification of Ovarian Tissue and Follicles in Primates, Mary Zelinski, PhD

Dr. Mary Zelinski is an Associate Scientist in the Division of Reproductive & Developmental Sciences, and Associate Professor in the Department of Obstetrics & Gynecology, Oregon Health & Science University. Her research centers on understanding the development and function of primate ovarian follicles.   She is currently developing ovarian tissue vitrification and follicle culture as novel options for female fertility preservation.

To watch her talk at the 2015 Conference, click here.

 

In anticipation of next year's conference, we will be featuring one of the 2015 lectures each week. You can receive our blog and other oncofertility updates directly to your inbox by signing up!

Global Partner in the News!

Leader of the Brazilian Oncofertility Consortium Wins a Recognized Research Prize in Brazil

Dr. Jhenifer Rodrigues recently was awarded a prestigious prize for her PhD disseration. Below is a blog from Dr. Rodrigues highlighting her success:

By Jhenifer Rodrigues, PhD

The researcher and leader of the Brazilian Oncofertility Consrtium, Dr. Jhenifer Rodrigues, PhD,  won an important prize in research in Brazil,  the Capes Thesis Award 2015, in recognition of a project developed as her Doctoral thesis in 2014.

The project, developed under the guidance of the professors Dr. Richard L Stouffer, PhD and Dr. Mary Zelinski, PhD from Oregon Health and Science University, USA, and also the professor Dr. Paula Navarro, PhD ( Human Reproduction Division from Ribeirão Preto School of Medicine (FMRP), USP, was funded in part by The Oncofertility Consortium and Fogarty.

Presentations from 2015 Conference- Ovarian Follicle Development, Teresa Woodruff, PhD

Today's feature is Dr. Woodruff's presentation from the 2015 Oncofertility Consortium Conference.

Dr. Woodruff's talk touched on three main points:

1. Updates on encapsulated in vitro follicle growth

2. New data on medical mitigation strategies

3. Next generation biomaterials and tissue scaffolds for tissue transplant

To watch the presentation in its entirety, click here.

In anticipation of next year's conference, we will be featuring one of the 2015 lectures each week. You can receive our blog and other oncofertility updates directly to your inbox by signing up!

Mark your calendar for the 2016 Oncofertility Conference: Expanding Access to Emerging and Existing Oncofertility Services, November 1-3, 2016!!
 

Dr. Woodruff featured in JAMA Oncology

Jama Oncology Logo

Dr. Woodruff was featured in an invited viewpoint in JAMA Oncology along with National Physicians Cooperative Leaders William Gradishar, MD and Kristin Smith, Fertility Preservation Patient Navigator.

 

 

Oncologists' Role in Patient Fertility Care: A Call to Action

Published Online: January 28, 2016

Presentations from the 2015 Conference Now Online!

All of the lectures from the 2015 Oncofertility Consortium Conference are now posted online! To view the complete list of presentations, click here.

In anticipation of next year's conference, we will be featuring one of the 2015 lectures each week. You can receive our blog and other oncofertility updates directly to your inbox by signing up!

Mark your calendar for the 2016 Oncofertility Conference: Expanding Access to Emerging and Existing Oncofertility Services, November 1-3, 2016!!

New Publication from Colleagues at University of Wisconsin-Madison

Screen Shot 2015-11-17 at 1.07.55 PMDr. Sana Salih and colleagues have published a new paper, Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice, on fertility preservation in young mice treated with chemotherapies.  Teresa Woodruff says that ‘fertoprotective therapies are the most important next step in research to protect ovarian function in women with cancer.’ Dr. Salih said that the most important points in the paper include ‘The fertoprotective drug, dexrazoxane (Dexra) pre-administration prevented ovarian damage and preserved fertility in pre-pubescent mice treated with doxorubicin (DXR) chemotherapy.